When you, the agent, work with CG Financial Group, you don’t have to “guess” how the life insurance carrier underwriters will rate certain conditions. We have an underwriter that CG Financial Group uses as a resource so you can shoot with a rifle versus a shotgun.

With that, we wanted to share an email dialogue that Charlie recently had with the underwriter regarding weight loss drugs. With tons of stories about people losing 30-40-50 pounds in 3 months while taking these “wonderdrugs”, needless to say, they are becoming increasingly popular. If you have owned shares of Eli Lilly stock over the last couple of years, then you know what we are talking about!!!

Agents have asked, “how does losing more weight than what a backstreet boy weighs impact my client’s life insurance underwriting?” Thus, Charlie’s conversation below with the underwriter.

Charlie’s question to the Underwriter: “Quick question, what is happening from a UW standpoint when one uses Ozempic?  Is that frowned on from carriers? Also, how do the carriers look at the large amount of weight that was lost?”

Underwriter’s Response:

Good morning Charlie, carriers aren’t taking adverse action on those using Ozempic, or any other medication like this to lose weight.  We typically need to know what their weight was prior to starting, how much they have lost and if they’ve kept the weight off for a full year or not.  If they haven’t kept the weight off for a full year, we do have to add 1/2 the weight lost back on to their current build.  Also, we look to be sure there isn’t any sign of diabetes that we would need to rate for as well and just making sure they aren’t having any adverse effects from the medication.  But carriers are treating it similar to any other weight loss medication and don’t add any rating just for using the medication itself.  

Now you know!!! And yes, she (the underwriter) is awesome. PS. Are you using CG Financial Group for your life cases?